SwanBio Therapeutics

Blood & Organ Banks · Pennsylvania, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

150 Monument Rd, Bala Cynwyd, Pennsylvan...

Phone Number

(610) 557-0600

Revenue

<$5 Million

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development

About SwanBio Therapeutics

Spur Therapeutics is a clinical-stage biotech company dedicated to developing life-changing gene therapies aimed at altering the course of diseases. The company focuses on optimizing gene therapy candidates to achieve significant clinical results, targeting conditions such as Gaucher disease and Parkinson's disease. Their mission is to redefine the potential of gene therapy, moving from rare diseases to more common conditions, thereby impacting a larger number of lives. Spur Therapeutics envisions a future where a single dose of genetic medicine can halt the progression of debilitating chronic conditions.Explore more
SwanBio Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Show more

SwanBio Therapeutics Org Chart

PhoneEmail
WD
United States flag for contact location.

Quality Control Head

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
OL
United States flag for contact location.

Lead Quality Control Analyst

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to SwanBio Therapeutics

Compare insights from companies similar to SwanBio Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

SwanBio Therapeutics

<$5M
11-50
Private
$108M
2017
WD
William DeCasereQuality Control Head
$25.4M
11-50
Private
<$5M
2007
IT
Irene TennantRegulatory Affairs Vice President, Clinical Development
<$5M
11-50
Public
$340.5M
2015
SV
Samara VioletSenior Director, Project Management
<$5M
11-50
Private
$555M
2018
PR
Patricia RiceVice President, Biostatistics & Data Management
<$5M
11-50
Private
$335M
2019
<$5M
51-200
Private
$185.8M
2001
Illustration of an envelope

SwanBio Therapeutics Tech Stack

A closer look at the technologies used by SwanBio Therapeutics

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding SwanBio Therapeutics

What is SwanBio Therapeutics's official website?
SwanBio Therapeutics's official website is www.swanbiotx.com
What is SwanBio Therapeutics's Revenue?
SwanBio Therapeutics's revenue is <$5 Million
What is SwanBio Therapeutics's SIC code?
SwanBio Therapeutics's SIC: 28,283
What is SwanBio Therapeutics's NAICS code?
SwanBio Therapeutics's NAICS: 32,325
How many employees does SwanBio Therapeutics have?
SwanBio Therapeutics has 11-50 employees
What industry does SwanBio Therapeutics belong to?
SwanBio Therapeutics is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is SwanBio Therapeutics competition?
SwanBio Therapeutics top competitors include: Bolt Biotherapeutics, Chiasma, Emalex Biosciences, American Gene Technologies International
What technology does SwanBio Therapeutics use?
Some of the popular technologies that SwanBio Therapeutics uses are: WordPress.org, PHP, Google Cloud DNS, Cloudflare CDN
How do I contact SwanBio Therapeutics?
SwanBio Therapeutics contact info: Phone number: (610) 557-0600 Website: www.swanbiotx.com
What does SwanBio Therapeutics do?

Spur Therapeutics is a clinical-stage biotech company dedicated to developing life-changing gene therapies aimed at altering the course of diseases. The company focuses on optimizing gene therapy candidates to achieve significant clinical results, targeting conditions such as Gaucher disease and Parkinson's disease. Their mission is to redefine the... potential of gene therapy, moving from rare diseases to more common conditions, thereby impacting a larger number of lives. Spur Therapeutics envisions a future where a single dose of genetic medicine can halt the progression of debilitating chronic conditions.Read More

What are SwanBio Therapeutics social media links?
SwanBio Therapeutics Linkedin page SwanBio Therapeutics Twitter page
Who invested in SwanBio Therapeutics?
SwanBio Therapeutics has 4 investors including Syncona, Mass General Brigham Ventures, Sycona and Partners Innovation Fund.
Is SwanBio Therapeutics a public company?
SwanBio Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about SwanBio Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.